Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: Updated analysis of 51 patients

Mathieu S. Bolhuis; Richard van Altena; Jan-Willem C. Alffenaar

doi:10.1093/jac/dks154

Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: Updated analysis of 51 patients

Mathieu S. Bolhuis^*
, Richard van Altena
, Jan-Willem C. Alffenaar

^*Corresponding author for this work

Microbes in Health and Disease (MHD)

Research output: Contribution to journal › Letter (Research letter) › Academic › peer-review

7 Citations (Scopus)

259 Downloads (Pure)

Original language	English
Pages (from-to)	2055-2056
Number of pages	2
Journal	Journal of Antimicrobial Chemotherapy
Volume	67
Issue number	8
DOIs	https://doi.org/10.1093/jac/dks154
Publication status	Published - 27-Apr-2012

Keywords

TB
efficacy
tolerability
adverse events
therapeutic drug monitoring

Access to Document

10.1093/jac/dks154

Comment on: Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patientsFinal publisher's version, 84.6 KBLicence: Unspecified

Handle.net

Persistent link

Cite this

@article{f511303e7dc84abe952c2fc9f0fe136f,

title = "Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: Updated analysis of 51 patients",

keywords = "TB, efficacy, tolerability, adverse events, therapeutic drug monitoring",

author = "Bolhuis, \{Mathieu S.\} and \{van Altena\}, Richard and Alffenaar, \{Jan-Willem C.\}",

year = "2012",

month = apr,

day = "27",

doi = "10.1093/jac/dks154",

language = "English",

volume = "67",

pages = "2055--2056",

journal = "Journal of Antimicrobial Chemotherapy",

issn = "0305-7453",

publisher = "Oxford University Press",

number = "8",

}

Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: Updated analysis of 51 patients. / Bolhuis, Mathieu S.; van Altena, Richard; Alffenaar, Jan-Willem C.
In: Journal of Antimicrobial Chemotherapy, Vol. 67, No. 8, 27.04.2012, p. 2055-2056.

Research output: Contribution to journal › Letter (Research letter) › Academic › peer-review

TY - JOUR

T1 - Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis

T2 - Updated analysis of 51 patients

AU - Bolhuis, Mathieu S.

AU - van Altena, Richard

AU - Alffenaar, Jan-Willem C.

PY - 2012/4/27

Y1 - 2012/4/27

KW - TB

KW - efficacy

KW - tolerability

KW - adverse events

KW - therapeutic drug monitoring

U2 - 10.1093/jac/dks154

DO - 10.1093/jac/dks154

M3 - Letter (Research letter)

SN - 0305-7453

VL - 67

SP - 2055

EP - 2056

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

IS - 8

ER -